Biomaterials for Rotary Blood Pumps
暂无分享,去创建一个
[1] T. Murakami,et al. Results of circulatory support for postoperative cardiogenic shock. , 1994, Artificial organs.
[2] H. Nishida,et al. Less platelet damage in the curved vane centrifugal pump: a comparative study with the roller pump in open heart surgery. , 1994, Artificial organs.
[3] J. Hoxie,et al. The Human Platelet Thrombin Receptor , 1994 .
[4] W. Oeveren,et al. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials , 1994 .
[5] H. Thoma,et al. In vitro investigation of thrombogenesis in rotary blood pumps. , 2008, Artificial organs.
[6] I. Yada,et al. Clinical experience using the Bio-pump for extracorporeal circulation during open-heart surgery. , 2008, Artificial organs.
[7] U Losert,et al. Minimization of Hemolysis in Centrifugal Blood Pumps: Influence of Different Geometries , 1993, The International journal of artificial organs.
[8] S. Goodman,et al. Integrin receptors and platelet adhesion to synthetic surfaces. , 1993, Journal of biomedical materials research.
[9] H. Matsuda,et al. Clinical application of percutaneous left ventricular support with a centrifugal pump. , 1993, ASAIO journal.
[10] B. Ratner,et al. Postadsorptive transitions in fibrinogen adsorbed to polyurethanes: changes in antibody binding and sodium dodecyl sulfate elutability. , 1992, Journal of biomedical materials research.
[11] C. Ternisien,et al. Thrombin Binding to Platelet Membrane Glycoprotein Ib , 1992, Seminars in thrombosis and hemostasis.
[12] J. Driessen,et al. Comparison of the standard roller pump and a pulsatile centrifugal pump for extracorporeal circulation during routine coronary artery bypass grafting , 1991, Perfusion.
[13] D. Massel,et al. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. , 1990, The Journal of clinical investigation.
[14] C. Abrams,et al. Direct detection of activated platelets and platelet-derived microparticles in humans. , 1990, Blood.
[15] P. Sims,et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. , 1988, The Journal of biological chemistry.
[16] J. Moake,et al. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin , 1988 .
[17] J. Sixma,et al. Fibronectin in Platelet Adhesion to Human Collagen Types I and III: Use of Nonfibrillar and Fibrillar Collagen in Flowing Blood Studies , 1988, Arteriosclerosis.
[18] A. Michelson,et al. Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex. , 1987, Blood.
[19] T. Chandy,et al. Protein-Polymer Interaction: Changes With Plasma Components, Vitamins, and Antiplatelet Drugs at the Interface , 1987 .
[20] D. Bienz,et al. Glycoprotein V is not the thrombin activation receptor on human blood platelets. , 1986, Blood.
[21] S. Harbottle,et al. Particle spallation induced by blood pumps in hemodialysis tubing sets. , 1986, Artificial organs.
[22] J. Joist,et al. Role of cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress. , 1983, The Journal of laboratory and clinical medicine.
[23] J. Fenton,et al. Selective immobilization of alpha-thrombin by surface-bound fibrin. , 1981, The Journal of laboratory and clinical medicine.
[24] S. Mohammad,et al. Interaction of human α‐thrombin with artificial surfaces and reactivity of adsorbed α‐thrombin , 1980 .
[25] G. Vilaire,et al. Exposure of platelet fibrinogen receptors by ADP and epinephrine. , 1979, The Journal of clinical investigation.